Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 3 days agoWho should wait, and who should get vaccinated now? The CDC advises that everyone ages 5 and older...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 3 days agoLast year, Novavax lost $5.41 per share and had $983.7 million in sales. This year, Wall Street...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 2 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
Is It Too Late to Buy Novavax Stock? | The Motley Fool
The Motley Fool· 3 days agoNovavax (NVAX -4.32%) stock is suddenly a buy again this year, with its stock price more than...
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
Fox News via Yahoo News· 2 days agoThe U.S. Food and Drug Administration (FDA) has recommended thatCOVID vaccine manufacturers update...
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
WFMZ Eastern Pennsylvania and Western New Jersey· 3 days agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
COVID Variant KP.3 Surges to Dominance—Here's What You Need to Know
Health via Yahoo News· 4 days agoCases are “stable or uncertain” in 18 others and are likely declining in one—Oklahoma. Do Vaccines...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 6 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 2 days agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
NBC New York· 7 days agoModerna said its combination vaccine targeting Covid and the flu was more effective than existing...